ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Tobacco Regulation: ACS Advocates Giving FDA Full Authority Over Tobacco

January 23, 1998

NIH announces The Cancer Genome Atlas, new name for human cancer genome project.

December 16, 2005

Congress Okays NIH Reauthorization, Allows NCI $472 Mil. More

June 12, 1992

Radioactive Seeds Tested In Treatment Of NSCLC

September 26, 2008

States Join Suit Alleging Amgen Offered Illegal Kickback To Doctors For Aranesp

November 6, 2009

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012